시장보고서
상품코드
1309565

세계의 식물성 원료의약품(API) 시장 규모, 점유율, 산업 동향 분석 리포트 : 최종 용도별, 분자 유형별, 지역별 전망과 예측(2023-2030년)

Global Plant-based API Market Size, Share & Industry Trends Analysis Report By End-use (Pharmaceuticals, Nutraceuticals, and Herbal Based Industries & Others), By Molecule Type, By Regional Outlook and Forecast, 2023 - 2030

발행일: | 리서치사: KBV Research | 페이지 정보: 영문 174 Pages | 배송안내 : 즉시배송


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

식물성 원료의약품(API) 시장 규모는 2030년까지 426억 달러에 달하며, 예측 기간 중 CAGR 5.8%의 시장 성장률로 상승할 것으로 예측됩니다.

지속가능하고 자연적인 제품에 대한 소비자의 욕구가 증가함에 따라 식물 유래 API에 대한 수요가 증가하고 있습니다. 사람들이 사용하는 제품이 환경에 미치는 영향에 대한 관심이 높아지면서 많은 고객들이 지속가능하고 자연적인 대체품에 대한 관심이 높아지고 있습니다. 그 결과 수많은 식물 유래 의약품이 개발되고 있습니다. 시장 성장을 가속하는 주요 요인 중 하나는 각국 정부의 헬스케어 산업에 대한 투자 건수 및 규모 증가입니다.

폭발적인 경제 성장과 의료비 상승으로 인해 양질의 의료서비스에 대한 접근성이 확대되는 신흥 국가들이 늘어날 것으로 예상됩니다. 헬스케어 산업에 대한 지출이 증가함에 따라 시장이 확대되고 있습니다. 많은 원료의약품 제조업체들은 특히 중요한 의약품 공급망에서 코로나 이전으로 돌아가고 있습니다. 대형 제약사들은 새로운 비즈니스 모델을 채택하고 국가별 KPI(핵심성과지표)에 기반한 솔루션을 제공합니다. 많은 국가에서 연구개발이 활발해지면서 식물 유래와 같은 새로운 원료의약품에 대한 혁신이 이루어지고 있습니다. 따라서 COVID-19는 시장에 다소 긍정적인 영향을 미쳤습니다.

그러나 식물성 원료의약품(API)을 둘러싼 규제 환경은 예측할 수 없습니다. 생약 연구에 대한 규제 요건을 충족하는 데 큰 격차가 있으며, 생약 규제 문제를 악화시키고 있습니다. 생약의 효능과 안전성을 입증할 수 있는 과학적 근거가 부족합니다. 따라서 이러한 모든 요소가 시장 성장을 저해하고 있습니다.

분자형 전망

분자 유형에 따라 시장은 알칼로이드, 안토시아닌, 플라보노이드, 페놀산, 테르페노이드, 리그닌 및 스틸벤, 기타로 분류됩니다. 테르페노이드 부문은 2022년 시장에서 상당한 성장률을 확보했습니다. 테르페노이드의 화학적 및 치료적 이점이 이 부문의 확장에 기여한 것으로 추정됩니다. 테르페노이드는 암을 포함한 다양한 질병을 예방하고 치료하는 데 도움이되는 특성을 가지고 있음이 입증되었습니다. 이러한 특성에는 항균, 항진균, 항기생충, 항알레르기, 항바이러스, 면역조절, 항경련, 항염증, 항고혈당 등이 포함됩니다.

최종 용도 전망

최종 용도별로 시장은 의약품, 건강 보조 식품, 허브 기반 산업 및 기타로 분류됩니다. 의약품 부문은 2022년 시장에서 가장 큰 매출 점유율을 기록했습니다. 이 부문의 성장은 만성질환의 발병률 증가와 최첨단 치료에 대한 시장의 요구가 증가했기 때문으로 분석됩니다. 의약품 및 백신 생산에 유전자 변형 작물을 사용하여 저렴한 비용으로 의약품을 공급할 수 있게된 것은 중요한 진전 중 하나입니다. 이러한 의약품공급과 유통에 있으며, 중요한 이해관계자들의 관심이 높아짐에 따라 환자가 보다 신속하게 의약품을 이용할 수 있는 식물 유래 의약품의 잠재력도 확대될 것으로 예상됩니다.

지역별 전망

지역별로 보면 시장은 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다. 북미 부문은 2022년 시장에서 가장 큰 매출 점유율을 차지했습니다. 노인 인구 증가와 국민들의 건강 인식이 높아지면서 이 지역 시장 확대에 기여하고 있습니다. 미국 인구 조사국에 따르면 2020년 미국의 1세 이상 인구는 5,580만 명으로 전체 인구의 16.8%를 차지할 것으로 예상됩니다. 건강 보조 식품이 만성질환을 예방할 수 있다는 생각이 널리 퍼져 있으므로 이 지역은 높은 보급률과 소비율을 보이고 있습니다. 노화 과정을 늦추는 것은 건강 증진과 만성질환을 예방하는 데 도움이 될 수 있습니다.

목차

제1장 시장 범위와 조사 방법

  • 시장의 정의
  • 목적
  • 시장 범위
  • 세분화
  • 조사 방법

제2장 시장 개요

  • 서론
    • 개요
      • 시장 구성과 시나리오
  • 시장에 영향을 미치는 주요 요인
    • 시장 촉진요인
    • 시장 억제요인

제3장 세계의 식물성 원료의약품(API) 시장 : 최종 용도별

  • 세계의 의약품 시장 : 지역별
  • 세계의 뉴트라슈티컬 시장 : 지역별
  • 세계의 허브 산업 및 기타 시장 : 지역별

제4장 세계의 식물성 원료의약품(API) 시장 : 분자 유형별

  • 세계의 알칼로이드 시장 : 지역별
  • 세계의 안토시아닌 시장 : 지역별
  • 세계의 플라보노이드 시장 : 지역별
  • 세계의 페놀산 시장 : 지역별
  • 세계의 리그닌 및 스틸벤 시장 : 지역별
  • 세계의 테르페노이드 시장 : 지역별
  • 세계의 기타 시장 : 지역별

제5장 세계의 식물성 원료의약품(API) 시장 : 지역별

  • 북미
    • 북미의 시장 : 국가별
      • 미국
      • 캐나다
      • 멕시코
      • 기타 북미 지역
  • 유럽
    • 유럽의 시장 : 국가별
      • 독일
      • 영국
      • 프랑스
      • 러시아
      • 스페인
      • 이탈리아
      • 기타 유럽 지역
  • 아시아태평양
    • 아시아태평양의 시장 : 국가별
      • 중국
      • 일본
      • 인도
      • 한국
      • 싱가포르
      • 말레이시아
      • 기타 아시아태평양
  • 라틴아메리카·중동 및 아프리카
    • 라틴아메리카·중동 및 아프리카의 시장 : 국가별
      • 브라질
      • 아르헨티나
      • 아랍에미리트
      • 사우디아라비아
      • 남아프리카공화국
      • 나이지리아
      • 기타 라틴아메리카·중동 및 아프리카

제6장 기업 개요

  • BASF SE
  • Cargill, Incorporated
  • Evonik Industries AG(RAG-Stiftung)
  • Roquette Freres SA
  • Arboris, LLC
  • Centroflora Group
  • Kothari Phytochemicals & Industries Ltd
  • Brains Bioceutical Corp
  • Indo Phytochem Pharmaceuticals
  • HimPharm
KSA 23.08.18

The Global Plant-based API Market size is expected to reach $42.6 billion by 2030, rising at a market growth of 5.8% CAGR during the forecast period.

The Plant-based API are majorly utilized in Pharmaceuticals to make a variety of medications and to provide a wide range of health advantages, therefore, the pharmaceutical sector registered $ 17,322.1 million revenue in the market in 2022. As chronic conditions like cancer, heart disease, and diabetes become more prevalent, there is an increasing demand for innovative and efficient therapies. The major causes of death in the United States, according to the CDC in 2022, were chronic diseases like diabetes, cancer, and heart disease. The country's $4.1 trillion in average healthcare costs per year are also largely attributable to them.

Similarly, according to the Australian Government, in 2020-21, one or more chronic illnesses were predicted to affect nearly half of Australians (11.6 million people or 47%). Therefore, the increasing chronic disease burden will aid in expanding the market. Some of the factors impacting the market are growing demand for sustainable and natural medicines, rise in healthcare industry investment levels, and issues like quality control, standardization, and sustainability of plant-based API.

Due to the rising consumer desire for sustainable and natural products, the demand for plant-based APIs is increasing. The environmental impact of what people use is becoming a growing concern for many customers, who are increasingly turning to sustainable and natural alternatives. As a result, numerous plant-based medications have been developed. One of the key factors boosting the market's growth is the increasing number and size of investments made in the healthcare industry by governments of different countries.

More emerging nations are anticipated to have expanded access to quality healthcare as a result of their explosive economic growth and rising healthcare costs. The market is growing as a result of rising healthcare industry spending. Many producers of APIs were returning to their pre-COVID initiatives, notably in the supply chain for vital medicines. Leading pharmaceutical companies are embracing new business models and providing solutions based on KPIs or key performance indicators per nation. Increased R&D in many nations resulted in the innovation of new APIs like plant-based. Therefore, the pandemic had a slightly positive impact on the market.

However, the regulatory environment surrounding plant-based APIs is unpredictable. A significant gap in fulfilling regulatory requirements for herbal medication research exacerbates the issue of herbal drug regulation. To establish the efficacy and safety of herbal medicines, there is inadequate scientific evidence. Hence, all these elements are hampering the growth of the market.

Molecule Type Outlook

Based on molecule type, the market is characterized into alkaloids, anthocyanin, flavonoids, phenolic acids, terpenoids, lignin & stilbenes, and others. The terpenoids segment procured a considerable growth rate in the market in 2022. The chemotherapeutic as well as therapeutic benefits of terpenoids are thought to be responsible for the segment's expansion. Terpenoids have been proven to have properties that make them beneficial in the prevention and treatment of a wide range of illnesses, including cancer. These properties include those that are antibacterial, antifungal, antiparasitic, antiallergenic, antiviral, immunomodulatory, antispasmodic, anti-inflammatory, and antihyperglycemic.

End Use Outlook

On the basis of end-use, the market is classified into pharmaceuticals, nutraceuticals, herbal based industries, and others. The pharmaceuticals segment recorded the largest revenue share in the market in 2022. The growth of the segment may be due to the rising incidence of chronic diseases and the market's growing need for cutting-edge treatments. The use of genetically engineered crops to produce drugs and vaccines, which helps provide medications at a reduced cost, is one of the significant advancements. As important stakeholders in the supply & distribution of such pharmaceuticals place a greater emphasis on them, the potential for plant-based pharmaceuticals to give patients speedier access to drugs is also expected to grow.

Regional Outlook

Region wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment garnered the maximum revenue share in the market in 2022. The increase in the geriatric population and the increased health consciousness among the populace are both credited with the market expansion in this region. According to the United States Census Bureau, in 2020, there were 55.8 million people over the age of one in the United States or 16.8% of the total population. Due to the widespread belief that nutraceuticals can prevent chronic diseases, the region exhibits strong adoption and consumption rates. Slowing down the aging process helps to promote health and prevent chronic diseases.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BASF SE, Evonik Industries AG (RAG-Stiftung), Cargill, Incorporated, Roquette Freres SA, Arboris, LLC, Centroflora Group, Kothari Phytochemicals & Industries Ltd., Brains Bioceutical Corp., Indo Phytochem Pharmaceuticals and HimPharm.

Scope of the Study

Market Segments covered in the Report:

By End-use

  • Pharmaceuticals
  • Nutraceuticals
  • Herbal Based Industries & Others

By Molecule Type

  • Alkaloids
  • Anthocyanin
  • Flavonoids
  • Phenolic Acids
  • Lignin & Stilbenes
  • Terpenoids
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • BASF SE
  • Evonik Industries AG (RAG-Stiftung)
  • Cargill, Incorporated
  • Roquette Freres SA
  • Arboris, LLC
  • Centroflora Group
  • Kothari Phytochemicals & Industries Ltd.
  • Brains Bioceutical Corp.
  • Indo Phytochem Pharmaceuticals.
  • HimPharm

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Plant-based API Market, by End-use
    • 1.4.2 Global Plant-based API Market, by Molecule Type
    • 1.4.3 Global Plant-based API Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Global Plant-based API Market by End-use

  • 3.1 Global Pharmaceuticals Market by Region
  • 3.2 Global Nutraceuticals Market by Region
  • 3.3 Global Herbal Based Industries & Others Market by Region

Chapter 4. Global Plant-based API Market by Molecule Type

  • 4.1 Global Alkaloids Market by Region
  • 4.2 Global Anthocyanin Market by Region
  • 4.3 Global Flavonoids Market by Region
  • 4.4 Global Phenolic Acids Market by Region
  • 4.5 Global Lignin & Stilbenes Market by Region
  • 4.6 Global Terpenoids Market by Region
  • 4.7 Global Others Market by Region

Chapter 5. Global Plant-based API Market by Region

  • 5.1 North America Plant-based API Market
    • 5.1.1 North America Plant-based API Market by End-use
      • 5.1.1.1 North America Pharmaceuticals Market by Country
      • 5.1.1.2 North America Nutraceuticals Market by Country
      • 5.1.1.3 North America Herbal Based Industries & Others Market by Country
    • 5.1.2 North America Plant-based API Market by Molecule Type
      • 5.1.2.1 North America Alkaloids Market by Country
      • 5.1.2.2 North America Anthocyanin Market by Country
      • 5.1.2.3 North America Flavonoids Market by Country
      • 5.1.2.4 North America Phenolic Acids Market by Country
      • 5.1.2.5 North America Lignin & Stilbenes Market by Country
      • 5.1.2.6 North America Terpenoids Market by Country
      • 5.1.2.7 North America Others Market by Country
    • 5.1.3 North America Plant-based API Market by Country
      • 5.1.3.1 US Plant-based API Market
        • 5.1.3.1.1 US Plant-based API Market by End-use
        • 5.1.3.1.2 US Plant-based API Market by Molecule Type
      • 5.1.3.2 Canada Plant-based API Market
        • 5.1.3.2.1 Canada Plant-based API Market by End-use
        • 5.1.3.2.2 Canada Plant-based API Market by Molecule Type
      • 5.1.3.3 Mexico Plant-based API Market
        • 5.1.3.3.1 Mexico Plant-based API Market by End-use
        • 5.1.3.3.2 Mexico Plant-based API Market by Molecule Type
      • 5.1.3.4 Rest of North America Plant-based API Market
        • 5.1.3.4.1 Rest of North America Plant-based API Market by End-use
        • 5.1.3.4.2 Rest of North America Plant-based API Market by Molecule Type
  • 5.2 Europe Plant-based API Market
    • 5.2.1 Europe Plant-based API Market by End-use
      • 5.2.1.1 Europe Pharmaceuticals Market by Country
      • 5.2.1.2 Europe Nutraceuticals Market by Country
      • 5.2.1.3 Europe Herbal Based Industries & Others Market by Country
    • 5.2.2 Europe Plant-based API Market by Molecule Type
      • 5.2.2.1 Europe Alkaloids Market by Country
      • 5.2.2.2 Europe Anthocyanin Market by Country
      • 5.2.2.3 Europe Flavonoids Market by Country
      • 5.2.2.4 Europe Phenolic Acids Market by Country
      • 5.2.2.5 Europe Lignin & Stilbenes Market by Country
      • 5.2.2.6 Europe Terpenoids Market by Country
      • 5.2.2.7 Europe Others Market by Country
    • 5.2.3 Europe Plant-based API Market by Country
      • 5.2.3.1 Germany Plant-based API Market
        • 5.2.3.1.1 Germany Plant-based API Market by End-use
        • 5.2.3.1.2 Germany Plant-based API Market by Molecule Type
      • 5.2.3.2 UK Plant-based API Market
        • 5.2.3.2.1 UK Plant-based API Market by End-use
        • 5.2.3.2.2 UK Plant-based API Market by Molecule Type
      • 5.2.3.3 France Plant-based API Market
        • 5.2.3.3.1 France Plant-based API Market by End-use
        • 5.2.3.3.2 France Plant-based API Market by Molecule Type
      • 5.2.3.4 Russia Plant-based API Market
        • 5.2.3.4.1 Russia Plant-based API Market by End-use
        • 5.2.3.4.2 Russia Plant-based API Market by Molecule Type
      • 5.2.3.5 Spain Plant-based API Market
        • 5.2.3.5.1 Spain Plant-based API Market by End-use
        • 5.2.3.5.2 Spain Plant-based API Market by Molecule Type
      • 5.2.3.6 Italy Plant-based API Market
        • 5.2.3.6.1 Italy Plant-based API Market by End-use
        • 5.2.3.6.2 Italy Plant-based API Market by Molecule Type
      • 5.2.3.7 Rest of Europe Plant-based API Market
        • 5.2.3.7.1 Rest of Europe Plant-based API Market by End-use
        • 5.2.3.7.2 Rest of Europe Plant-based API Market by Molecule Type
  • 5.3 Asia Pacific Plant-based API Market
    • 5.3.1 Asia Pacific Plant-based API Market by End-use
      • 5.3.1.1 Asia Pacific Pharmaceuticals Market by Country
      • 5.3.1.2 Asia Pacific Nutraceuticals Market by Country
      • 5.3.1.3 Asia Pacific Herbal Based Industries & Others Market by Country
    • 5.3.2 Asia Pacific Plant-based API Market by Molecule Type
      • 5.3.2.1 Asia Pacific Alkaloids Market by Country
      • 5.3.2.2 Asia Pacific Anthocyanin Market by Country
      • 5.3.2.3 Asia Pacific Flavonoids Market by Country
      • 5.3.2.4 Asia Pacific Phenolic Acids Market by Country
      • 5.3.2.5 Asia Pacific Lignin & Stilbenes Market by Country
      • 5.3.2.6 Asia Pacific Terpenoids Market by Country
      • 5.3.2.7 Asia Pacific Others Market by Country
    • 5.3.3 Asia Pacific Plant-based API Market by Country
      • 5.3.3.1 China Plant-based API Market
        • 5.3.3.1.1 China Plant-based API Market by End-use
        • 5.3.3.1.2 China Plant-based API Market by Molecule Type
      • 5.3.3.2 Japan Plant-based API Market
        • 5.3.3.2.1 Japan Plant-based API Market by End-use
        • 5.3.3.2.2 Japan Plant-based API Market by Molecule Type
      • 5.3.3.3 India Plant-based API Market
        • 5.3.3.3.1 India Plant-based API Market by End-use
        • 5.3.3.3.2 India Plant-based API Market by Molecule Type
      • 5.3.3.4 South Korea Plant-based API Market
        • 5.3.3.4.1 South Korea Plant-based API Market by End-use
        • 5.3.3.4.2 South Korea Plant-based API Market by Molecule Type
      • 5.3.3.5 Singapore Plant-based API Market
        • 5.3.3.5.1 Singapore Plant-based API Market by End-use
        • 5.3.3.5.2 Singapore Plant-based API Market by Molecule Type
      • 5.3.3.6 Malaysia Plant-based API Market
        • 5.3.3.6.1 Malaysia Plant-based API Market by End-use
        • 5.3.3.6.2 Malaysia Plant-based API Market by Molecule Type
      • 5.3.3.7 Rest of Asia Pacific Plant-based API Market
        • 5.3.3.7.1 Rest of Asia Pacific Plant-based API Market by End-use
        • 5.3.3.7.2 Rest of Asia Pacific Plant-based API Market by Molecule Type
  • 5.4 LAMEA Plant-based API Market
    • 5.4.1 LAMEA Plant-based API Market by End-use
      • 5.4.1.1 LAMEA Pharmaceuticals Market by Country
      • 5.4.1.2 LAMEA Nutraceuticals Market by Country
      • 5.4.1.3 LAMEA Herbal Based Industries & Others Market by Country
    • 5.4.2 LAMEA Plant-based API Market by Molecule Type
      • 5.4.2.1 LAMEA Alkaloids Market by Country
      • 5.4.2.2 LAMEA Anthocyanin Market by Country
      • 5.4.2.3 LAMEA Flavonoids Market by Country
      • 5.4.2.4 LAMEA Phenolic Acids Market by Country
      • 5.4.2.5 LAMEA Lignin & Stilbenes Market by Country
      • 5.4.2.6 LAMEA Terpenoids Market by Country
      • 5.4.2.7 LAMEA Others Market by Country
    • 5.4.3 LAMEA Plant-based API Market by Country
      • 5.4.3.1 Brazil Plant-based API Market
        • 5.4.3.1.1 Brazil Plant-based API Market by End-use
        • 5.4.3.1.2 Brazil Plant-based API Market by Molecule Type
      • 5.4.3.2 Argentina Plant-based API Market
        • 5.4.3.2.1 Argentina Plant-based API Market by End-use
        • 5.4.3.2.2 Argentina Plant-based API Market by Molecule Type
      • 5.4.3.3 UAE Plant-based API Market
        • 5.4.3.3.1 UAE Plant-based API Market by End-use
        • 5.4.3.3.2 UAE Plant-based API Market by Molecule Type
      • 5.4.3.4 Saudi Arabia Plant-based API Market
        • 5.4.3.4.1 Saudi Arabia Plant-based API Market by End-use
        • 5.4.3.4.2 Saudi Arabia Plant-based API Market by Molecule Type
      • 5.4.3.5 South Africa Plant-based API Market
        • 5.4.3.5.1 South Africa Plant-based API Market by End-use
        • 5.4.3.5.2 South Africa Plant-based API Market by Molecule Type
      • 5.4.3.6 Nigeria Plant-based API Market
        • 5.4.3.6.1 Nigeria Plant-based API Market by End-use
        • 5.4.3.6.2 Nigeria Plant-based API Market by Molecule Type
      • 5.4.3.7 Rest of LAMEA Plant-based API Market
        • 5.4.3.7.1 Rest of LAMEA Plant-based API Market by End-use
        • 5.4.3.7.2 Rest of LAMEA Plant-based API Market by Molecule Type

Chapter 6. Company Profiles

  • 6.1 BASF SE
    • 6.1.1 Company Overview
    • 6.1.2 Financial Analysis
    • 6.1.3 Segmental and Regional Analysis
    • 6.1.4 Research & Development Expense
    • 6.1.5 SWOT Analysis
  • 6.2 Cargill, Incorporated
    • 6.2.1 Company Overview
  • 6.3 Evonik Industries AG (RAG-Stiftung)
    • 6.3.1 Company Overview
    • 6.3.2 Financial Analysis
    • 6.3.3 Segmental and Regional Analysis
    • 6.3.4 Research & Development Expenses
    • 6.3.5 Recent strategies and developments:
      • 6.3.5.1 Product Launches and Product Expansions:
      • 6.3.5.2 Acquisition and Mergers:
  • 6.4 Roquette Freres SA
    • 6.4.1 Company Overview
  • 6.5 Arboris, LLC
    • 6.5.1 Company Overview
  • 6.6 Centroflora Group
    • 6.6.1 Company Overview
  • 6.7 Kothari Phytochemicals & Industries Ltd.
    • 6.7.1 Company Overview
    • 6.7.2 Financial Analysis
    • 6.7.3 Segmental and Regional Analysis
  • 6.8 Brains Bioceutical Corp.
    • 6.8.1 Company Overview
  • 6.9 Indo Phytochem Pharmaceuticals
    • 6.9.1 Company Overview
  • 6.10. HimPharm
    • 6.10.1 Company Overview
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제